MCOA is dedicated to advancing the field of Ophthalmology through research, clinical studies and the development of new instruments and techniques. We are engaged in multiple clinical research trials of new therapies for various ophthalmological diseases. You will find information about some of these studies below.
Wet Age-Related Macular Degeneration
Allergan Cedar – Phase 3 study for wet age-related macular degeneration
Daiichi – Phase 1 Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration
Genentech Ladder – Phase 3 Port sustained delivery system of Ranibizumab for Patients with Wet nAmd
Ohr MAKO – Phase 3 study for wet age-related macular degeneration
Diabetic Macular Edema
Allegro DME – A Phase 2, Multi-Center, Randomized, Controlled, Double-Masked Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate (ALD-1001) as Compared to Avastin in the Treatment of Diabetic Macular Edema
Roche Boulevard DME – A phase 2 study for diabetic macular edema
Eyegate – A Prospective, Multi-Center, Randomized Double-Masked, Positive- Controlled, Phase 3 Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution Compared to Prednisolone Acetate Ophthalmic Suspension (1%) in Patients with Non-Infectious Anterior Segment Uveitis
Regeneron Panorama – A phase 3 study for diabetic retinopathy
A typical clinical trial visit could include the following:
* Note all Procedures are protocol dependent *
Participants of MCOA clinical research will have the newest treatments available to treat related eye problems. We have an expert team comprised of knowledgeable doctors and staff, who will follow you through the trial process. Many of today’s complex eye diseases are genetic and do not yet have effective treatments. Our research is leading the way for new effective ways to treat current eye diseases. There are many benefits to participating in a clinical trial with us.
If you or someone you know is interested in finding out more, please contact us by either calling our Clinical Trials department at 210-697-2006, our main number at 210-697-2020 or email us.